CN101732638B - Chinese medicament for treating pulmonary tuberculosis - Google Patents
Chinese medicament for treating pulmonary tuberculosis Download PDFInfo
- Publication number
- CN101732638B CN101732638B CN2010101024429A CN201010102442A CN101732638B CN 101732638 B CN101732638 B CN 101732638B CN 2010101024429 A CN2010101024429 A CN 2010101024429A CN 201010102442 A CN201010102442 A CN 201010102442A CN 101732638 B CN101732638 B CN 101732638B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicament
- decoction
- treating
- pulmonary tuberculosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicament for treating white plague, and aims to provide a Chinese medicament which is used for treating the white plague, and has quick response, good treatment effect, high cure rate and no side effect basically. The Chinese medicament for treating the white plague is prepared from the following raw materials in part by weight: 30 to 50 parts of Chinese mahonia leaf, 10 to 20 parts of ginkgo seed, 10 to 20 parts of sessile stemona root, 10 to 20 parts of bletilla, 10 to 20 parts of andrographis paniculata, 10 to 20 parts of beautiful millettia root and 10 to 20 parts of common selfheal fruit-spike; and the Chinese medicament is a decoction prepared by adding water into the seven raw materials for decoction and filtering residue. According to a formula, one dose is added with water and decocted into the decoction everyday; the decoction is taken by two to three times; and through clinical application, the Chinese medicament has satisfactory treatment effect on the white plague.
Description
Technical field
The invention belongs to Chinese medicine, more specifically to a kind of Chinese medicine for the treatment of pulmonary tuberculosis.
Background technology
Pulmonary tuberculosis is the chronic infectious disease that is caused by tubercule bacillus.Pulmonary tuberculosis is modal a kind of in the tuberculosis.In 19th century, do not know to have how many people once to be seized relatives or friend by the deadly infectious disease of this mercilessness.Along with coming out one after another of medicines such as specific drug streptomycin, isoniazid, rifampicin, ethambutol, lunger's number is significantly reduced.Though 20th century multiple effective antibiotic and the generation of prophylactic agent the pulmonary tuberculosis case is worldwide reduced rapidly, but therefore lose vigilance, when on March 24th, 2003 " World Tuberculosis Prevention and Cure Day ", the numeral that " prevention tuberculosis " world action tissue is announced shows, the whole world still has 5000 people to die from tuberculosis every day at present, surpasses 8,000,000 and suffer from number lungy every year.In recent years because antibiotic abuse and treat lack of standardizationly makes large quantities of tuberculosis patients produce the drug resistance phenomenons.According to statistics, the resistant tuberculosis patient accounts for the 28%-41% of therapist sum first.This has just beaten alarm bell to people: tuberculosis is bad have been controlled, and there have 1/3 patient once to control to be bad, and the therapeutic alliance of life-time service Western medicine, it takes effect slowly, and the course of treatment is long, and side effect is big.In recent years again because deterioration of environment quality, the essential water of people's daily life, air, food etc. all have been subjected to industrial pollution, and people's resistivity has descended, and by airborne tuberculosis revivable gesture is arranged.
Summary of the invention
The Chinese medicine of the treatment pulmonary tuberculosis that the purpose of this invention is to provide a kind of instant effect, good effect, cure rate height and have no side effect substantially.
A kind of Chinese medicine for the treatment of pulmonary tuberculosis of the present invention, it is characterized in that making: Folium Mahoniae 30-50, Semen Ginkgo 10-20, Radix Stemonae 10-20, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-20, Herba Andrographitis 10-20, Millettia Speciosa 10-20 and Spica Prunellae 10-20 by the raw material of following weight parts, and described Chinese medicine is that above-mentioned 7 flavor raw materials decoct with water the decoction that the elimination slag becomes.
The pulmonary tuberculosis traditional Chinese medical science claims " pulmonary tuberculosis ", and the traditional Chinese medical science is thought lung tender dirty for void clearly, and " pulmonary tuberculosis " is that the consumptive disease worm is invaded in lung, and lung qi is impaired, and asthenic fire is burnt Tianjin and given birth to expectorant, and damage lung network is then spat blood." kill its worm first with exhausted basic, mend its void first with multiple its true unit " promptly proposed in bright " the medical science main story consumptive disease utmost point ".So its Therapeutic Principle is: 1. invigorating deficiency and tonifying vital QI: the pulmonary tuberculosis focus should be based on tonifying the lung gas, lung benefiting the moon at lung, and spleen is involved in prolonged illness, kidney two is dirty, and suitable training is unit very; 2. anti-consumptive disease worm extremely: the consumptive disease worm is the basic of the cause of disease, cures the disease and effects a permanent cure earlier, so need the anti-consumptive disease worm that kills.Among the we: Folium Mahoniae have the heat clearing away tonify deficiency, and the effect of relieving cough and resolving phlegm is controlled pulmonary tuberculosis hemoptysis, osteopyrexia and fever, and the lung heat clearing fire is arranged, and the effect of lung benefiting the moon again can detumescence and apocenosis, are the indispensable medicines of treatment lung disease.The Semen Ginkgo QI invigorating nourishes heart, the kidney tonifying YIN nourishing, and the cough-relieving relieving restlessness, slightly poisonous, utilizing mild toxicity to kill the consumptive disease worm is a kind of good medicine.The Pseudobulbus Bletillae (Rhizoma Bletillae) is ended lung blood, granulation promoting, detumescence effect, the kind lung disease of controlling.Herba Andrographitis has heat-clearing and toxic substances removing, removing heat from blood, detumescence effect.The lung moistening of Millettia Speciosa tonify deficiency, strong muscle is active.Spica Prunellae heat-clearing and toxic substances removing, hard masses softening and resolving, drive the stagnation resolvation tumor.Since the synergism of above-mentioned each medicine energy health invigorating, the resistance against diseases of regulating body.Use 12 routine patients, at 52~78 years old age, average 65 years old, treat 72~180 days (average course of treatment 140 days).Take the photograph sheet inspection and the inspection of expectorant bacterium through X-ray, wherein produce effects 6 examples (the focus scope absorbs more than 2/3, and the cavity is closed, and the expectorant bacterium is turned out cloudy); Effective 4 examples (the focus scope absorbs more than 2/3, and the cavity dwindles, and expectorant bacterium number reduces), total effective rate 83.3%, invalid 2 examples.After followed up a case by regular visits to 8 examples in 4 years, recur 1 example, the recurrence patient is overworked for curing the back, does not strengthen after treatment.Also very important according to clinical empirical summary more back after treatment.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Material name | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 |
Folium Mahoniae | 30 | 50 | 35 | 40 | 45 |
Semen Ginkgo | 10 | 20 | 15 | 12 | 18 |
The Radix Stemonae | 15 | 18 | 12 | 10 | 20 |
The Pseudobulbus Bletillae (Rhizoma Bletillae) | 20 | 10 | 18 | 15 | 12 |
Herba Andrographitis | 10 | 20 | 12 | 18 | 15 |
Millettia Speciosa | 20 | 12 | 10 | 15 | 18 |
Spica Prunellae | 18 | 20 | 12 | 15 | 10 |
According to decocting with water into decoction 1 dose of above-mentioned prescription every day, divide and take for 2-3 time, through clinical practice pulmonary tuberculosis there is satisfied curative effect.
Claims (1)
1. Chinese medicine for the treatment of pulmonary tuberculosis, it is characterized in that making: Folium Mahoniae 30-50, Semen Ginkgo 10-20, Radix Stemonae 10-20, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-20, Herba Andrographitis 10-20, Millettia Speciosa 10-20 and Spica Prunellae 10-20 by the raw material of following weight parts, and described Chinese medicine is that above-mentioned 7 flavor raw materials decoct with water the decoction that the elimination slag becomes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101024429A CN101732638B (en) | 2010-01-22 | 2010-01-22 | Chinese medicament for treating pulmonary tuberculosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101024429A CN101732638B (en) | 2010-01-22 | 2010-01-22 | Chinese medicament for treating pulmonary tuberculosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101732638A CN101732638A (en) | 2010-06-16 |
CN101732638B true CN101732638B (en) | 2011-06-01 |
Family
ID=42457006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101024429A Expired - Fee Related CN101732638B (en) | 2010-01-22 | 2010-01-22 | Chinese medicament for treating pulmonary tuberculosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101732638B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906481A (en) * | 2015-07-11 | 2015-09-16 | 陈四新 | Preparation method for medicine for treating pulmonary tuberculous cavity |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1814176A (en) * | 2005-12-05 | 2006-08-09 | 杨雄志 | Chinese medicine composition for treating phthisis and use thereof |
CN101559186A (en) * | 2009-05-27 | 2009-10-21 | 高春喜 | Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis |
-
2010
- 2010-01-22 CN CN2010101024429A patent/CN101732638B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1814176A (en) * | 2005-12-05 | 2006-08-09 | 杨雄志 | Chinese medicine composition for treating phthisis and use thereof |
CN101559186A (en) * | 2009-05-27 | 2009-10-21 | 高春喜 | Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis |
Non-Patent Citations (2)
Title |
---|
乔富渠.肺结核的中医证治.《陕西中医》.1989,第10卷(第05期),235-236. * |
康雁翔等.中西医结合治疗肺结核概况.《山西中医》.2008,第24卷(第02期),58-60. * |
Also Published As
Publication number | Publication date |
---|---|
CN101732638A (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463500B (en) | Medicament for treating cerebral hemorrhage | |
CN102688383A (en) | Traditional Chinese medicine composite for treating body surface ulcer or fester | |
CN103041250B (en) | Pharmaceutical composition for treating tuberculosis | |
CN101259242B (en) | Medicine for treating allergic rhinitis | |
CN101732638B (en) | Chinese medicament for treating pulmonary tuberculosis | |
CN101721494B (en) | Traditional Chinese medicine for treating cervical tuberculous lymphadenitis | |
CN104206444B (en) | A kind of electric liquid device fragrant containing lavender natural and preparation method | |
CN102727639B (en) | External-use medicine for treating venereal disease | |
CN104887892A (en) | Traditional Chinese medicine for treating bacillary dysentery | |
CN104224905A (en) | Chinese herbal medicine for quickly treating nasal diseases | |
CN104740443A (en) | Traditional Chinese medicine compound essential oil | |
CN102824456A (en) | Specific medicine for treating animal aftosa | |
CN103285290B (en) | Chinese medicinal composition for treating ascariasis of biliary tract | |
CN101129602A (en) | Medicament for treating diabetes and nephropathy | |
CN103041249B (en) | Drug for treating tuberculosis | |
CN103816358A (en) | Traditional Chinese medicinal composition for clearing lung and eliminating phlegm | |
CN104958460A (en) | External lotion for treating scabies and preparation method | |
CN103041248B (en) | Medicament for treating tuberculosis | |
CN103638433B (en) | One treats pleuritic pure Chinese medicine composition | |
CN103977313A (en) | Diuresis promoting and itching relieving pills and preparation method thereof | |
CN102920894B (en) | Medicament for treating arthralgia and myalgia and preparation method thereof | |
CN103845483A (en) | Traditional Chinese medicine for treating hepatitis B | |
CN103372192A (en) | Medicament for treating bronchial asthma | |
CN102114183A (en) | Medicament for treating hypertension | |
CN105169353A (en) | Traditional Chinese medicine for treating secretory otitis media |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110601 Termination date: 20130122 |